In recent years, therapeutic antibodies have transformed the treatment of cancer and autoimmune diseases. Now, researchers have developed a new, efficient method based on the genetic scissors CRISPR-Cas9, that facilitates antibody development.
In recent years, therapeutic antibodies have transformed the treatment of cancer and autoimmune diseases. Now, researchers have developed a new, efficient method based on the genetic scissors CRISPR-Cas9, that facilitates antibody development.